THE SCARLESS HEALER

B7-33

Grade BGood

Fight scarring and fibrosis with this relaxin-based peptide

Also known as: Relaxin-2 analog B7-33

Accelerated Healing
Cardiovascular Support
Anti-Fibrotic

Overview

B7-33 is an engineered version of relaxin-2, a hormone that prevents tissue scarring. It works by stopping fibroblasts from depositing excess collagen and scar tissue. Unlike natural relaxin, B7-33 provides the anti-fibrotic benefits without causing significant blood pressure drops, making it safer for long-term use.

Key Benefits & Mechanisms

Anti-Fibrotic

Stops fibroblasts from producing excess scar tissue

Matrix Remodeling

Activates enzymes that break down excess collagen

Anti-Inflammatory

Reduces inflammatory cytokines while boosting protective ones

Tissue Regeneration

Promotes new blood vessel growth and tissue healing

Dosing Guide

Dosage

250 mcg daily

Schedule

daily

Cycle

1 week on, 1 week off

Pro Tip

Subcutaneous injection; research protocols often use 250 mcg/kg twice daily

Safety Profile

B

Good Safety

Good

Designed to be safer than native relaxin with fewer cardiovascular effects.

Research compound. Minimal vasodilatory side effects compared to natural relaxin.

Possible Side Effects

Localized injection site reactions

What to Expect

Week 1

Anti-inflammatory signaling begins

Week 2-4

Collagen remodeling and reduced fibrotic markers

Week 4+

Measurable tissue improvement in affected organs

Anti-fibrotic effects develop over weeks; tissue remodeling is a slow process.

Who Is This For

People with pulmonary fibrosis
Those with cardiac fibrosis or stiffness
Liver fibrosis patients
Anyone concerned about tissue scarring
Post-surgical healing support

Research References

Related Peptides

Ready to Start Your Peptide Journey?

Track your protocols, get guided reconstitution, and access our vetted vendor network — all in one app.

Download The Peptide App